CASAMENTI, FIORELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.563
EU - Europa 6.177
AS - Asia 1.764
SA - Sud America 313
OC - Oceania 94
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.978
Nazione #
US - Stati Uniti d'America 8.525
RU - Federazione Russa 1.828
PL - Polonia 1.678
SG - Singapore 595
HK - Hong Kong 581
IE - Irlanda 558
SE - Svezia 554
IT - Italia 462
DE - Germania 340
BR - Brasile 276
UA - Ucraina 258
CN - Cina 227
FI - Finlandia 189
GB - Regno Unito 106
IN - India 104
AU - Australia 94
FR - Francia 78
JO - Giordania 65
TR - Turchia 59
CH - Svizzera 38
VN - Vietnam 34
CI - Costa d'Avorio 30
ID - Indonesia 20
NL - Olanda 20
BE - Belgio 19
ES - Italia 17
CA - Canada 16
SC - Seychelles 13
JP - Giappone 10
LT - Lituania 9
MX - Messico 9
AR - Argentina 8
BD - Bangladesh 8
IQ - Iraq 8
PT - Portogallo 8
ZA - Sudafrica 8
EC - Ecuador 7
KR - Corea 7
PK - Pakistan 7
AZ - Azerbaigian 6
PE - Perù 6
SA - Arabia Saudita 6
EU - Europa 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
RO - Romania 4
UZ - Uzbekistan 4
BG - Bulgaria 3
CO - Colombia 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
MA - Marocco 3
TW - Taiwan 3
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
CL - Cile 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MU - Mauritius 2
MY - Malesia 2
PA - Panama 2
PY - Paraguay 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LV - Lettonia 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 16.978
Città #
Santa Clara 2.088
Warsaw 1.676
Fairfield 932
Chandler 646
Dublin 558
Jacksonville 477
Hong Kong 458
Ashburn 429
Woodbridge 414
Cambridge 353
Singapore 330
Seattle 328
Wilmington 305
Houston 299
Ann Arbor 185
Princeton 156
Florence 114
Boardman 111
Beijing 108
Munich 101
Boston 96
Melbourne 91
Medford 84
Altamura 81
Mumbai 81
Lawrence 76
Buffalo 66
San Diego 49
Izmir 43
Moscow 43
New York 43
Bern 36
Turku 36
Shanghai 34
Norwalk 33
Abidjan 30
Falls Church 29
Paris 27
Dong Ket 26
Dearborn 25
Bremen 24
Hillsboro 22
Portsmouth 21
Rome 21
Brussels 19
Jakarta 19
Milan 19
Lauterbourg 18
Los Angeles 18
Auburn Hills 13
Helsinki 13
Kent 13
São Paulo 12
West Jordan 12
Phoenix 11
Yubileyny 11
Andover 10
Barcelona 9
Frankfurt Am Main 9
Tappahannock 9
Toronto 9
Toulouse 9
Verona 8
Rio de Janeiro 7
Santa Maria A Monte 7
Baku 6
Düsseldorf 6
Hefei 6
Laurel 6
Salerno 6
The Dalles 6
Usingen 6
Ankara 5
Chicago 5
Dhaka 5
Guangzhou 5
London 5
Rimini 5
Amsterdam 4
Bradford 4
Brooklyn 4
Campinas 4
Chieti 4
Curitiba 4
Goiânia 4
Guayaquil 4
Jena 4
Karachi 4
Nanjing 4
Recife 4
Redmond 4
São José dos Campos 4
Tokyo 4
Valencia 4
Almaty 3
Belo Horizonte 3
Betim 3
Brasília 3
Brescia 3
Brumadinho 3
Totale 11.594
Nome #
Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease 299
Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: A mechanistic insight 293
The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology 293
Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ß toxicity: biochemical, epigenetic and functional correlates 288
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 274
Lithium Improves Hippocampal Neurogenesis,Neuropathology and Cognitive Functions in APP MutantMice 273
The Brain Cholinergic System in Neurodegenerative Diseases 265
Young human cholinergic neurons respond to physiological regulators and improve cognitive symptoms in an animal model of Alzheimer’s disease 261
Employing AD animal models for translational research: focus on dietary components 247
Neurodegeneration and the cholinergic system 232
Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. 217
The polyphenol oleuropein aglycone modulates the PARP1-SIRT1 interplay: an in vitro and in vivo study 202
Farmaci per le malattie neurodegenerative 197
Different Patterns of Neurodegeneration and Glia Activation in CA1 and CA3 Hippocampal Regions of TgCRND8 Mice 191
Successful Brain Delivery of Andrographolide Loaded in Human Albumin Nanoparticles to TgCRND8 Mice, an Alzheimer’s Disease Mouse Model 180
A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer's Disease 169
Abnormal processing of tau in the brain of aged TgCRND8 mice 159
Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. 156
STEREOSELECTIVE INCREASE IN CHOLINERGIC TRANSMISSION BY R-(+)- HYOSCYAMINE 153
Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice 152
Olive oil polyphenols can be useful to prevent aging-associated neurodegeneration 151
Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. 151
Development of Blood-Brain Barrier Permeable Nanoparticles as Potential Carriers for Salvianolic Acid B to CNS 150
Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. 149
Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N 147
Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease 145
Long-term neuro-glial co-cultures as a brain aging model: hallmarks of senescence, miRNA expression profiles and comparison with in vivo models 144
A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells 143
Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology 142
BRAIN-TARGETED DELIVERY OF ANDROGRAPHOLIDE USING SOLID LIPID NANOPARTICLES: IN VITRO AND IN VIVO EVALUATION 142
ARE THE NEUROCHEMICAL AND BEHAVIORAL CHANGES INDUCED BY LESIONS OF THE NUCLEUS BASALIS IN THE RAT A MODEL OF ALZHEIMER'S DISEASE? 141
C-fos expression in the rat nucleus basalis upon excitotoxic lesion with quisqualic acid: a study in adult and aged animals 137
Olive polyphenols: new promising agents to combat aging-associated neurodegeneration 137
Neutrophils CD11b and fibroblasts PGE2 are elevated in Alzheimer's disease 136
Aβ plaque-associated glial reaction as a determinant of apoptotic neuronal death and cortical gliogenesis: a study in APP mutant mice 134
Novel S-acyl glutathione derivatives prevent amyloid oxidative stress and cholinergic dysfunction in Alzheimer disease models. Free Radic Biol Med. 134
Lesions of cholinergic forebrain nuclei: changes in avoidance behavior and scopolamine actions. 133
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. 133
Extracellular chaperones prevent Aβ42-induced toxicity in rat brains 133
Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain 131
Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition. 131
Cholinergic dysfunction, neuronal damage and axonal loss in TGCRND8 mice. 130
Inhibition of acetylcholine-induced activation of extracellular regulated protein kinase prevents the encoding of an inhibitory avoidance response in the rat 130
Poly(ethyl cyanoacrylate) nanoparticles for brain delivery of andrographolide 130
Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. 129
Postnatal development of functional properties of visual cortical cells in rats with excitotoxic lesions of basal forebrain cholinergic neurons. 128
Activation of brain cholinergic system by noncholinomimetic agents 127
Long-term ethanol consumption by rats: effect on acetylcholine release in vivo, choline acetyltransferase activity, and behavior. 126
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. 126
Acetylcholine release from fetal tissue homotopically grafted to the motoneuron-depleted lumbar spinal cord. An in vivo microdialysis study in the awake rat. 125
The release of endogenous GABA and glutamate from the cerebral cortex in the rat. 124
Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. 124
Effect of phosphatidylserine on acetylcholine output from the cerebral cortex of the rat. 123
An analysis of cholecystokinin-induced increase in acetylcholine output from cerebral cortex of the rat. 123
Effects of 4-aminopyridine on acetylcholine output from the cerebral cortex of the rat in vivo. 120
The brain cholinergic system as a target of cognition enhancers 120
Effect of nerve growth factor and GM1 ganglioside on the recovery of cholinergic neurons after a lesion of the nucleus basalis in aging rats 119
Aging of brain cholinergic neurons: pharmacological interventions. 119
Unilateral and bilateral nucleus basalis lesions: differences in neurochemical and behavioural recovery. 118
Garcinoic acid prevents β-amyloid (Aβ) deposition in the mouse brain 118
Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nuclei. 117
Acetylcholine release in freely moving rats by means of transversal dialysis coupled to an HPLC with electrochemical detection 116
Employing AD animal models for effective translational research 115
Prefibrillar amyloid aggregates could be generic toxins in higher organisms 115
Changes in presynaptic proteins, SNAP-25 and synaptophysin, in the hippocampal CA1 area in ischemic gerbils. 114
Rivastigmine antagonises deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis 114
Oleuropein aglycon relieves memory impairments, induces brain autophagy and reduces Aß load in the TgCRND8 mouse model of Alzheimer’s Disease 113
Hyperphosphorylation and deposition of tau in the brain of a human APP transgenic mouse model 112
Combined treatment with atorvastatin and minocycline suppresses severity of EAE 111
The brain cholinergic system in ageing mammals. 111
Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes 109
Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. 109
NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain 108
Effect of BM-5, a presynaptic antagonist-postsynaptic agonist, on cortical acetylcholine release. 108
Acetylcholine output from the cerebral cortex, choline uptake and muscarinic receptors in morphine dependent freely-moving rats. 108
Induction of inflammatory mediators and microglial activation in mice transgenic for human P301S tau protein 108
Selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis impairs prepulse inhibition of acoustic startle. 107
Amyloid ß-peptides injection into the cholinergic nuclei: Morphological, neurochemical and behavioral effects 106
Albumin Nanoparticles for Brain Delivery: A Comparison of Chemical versus Thermal Methods and invivo Behavior 105
Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway 105
Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behavior 105
Adult hippocampal neurogenesis and cortical gliogenesis in APP mutant mice 105
Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase and high affinity choline uptake decrease after lesion of the nucleus basalis. 104
Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1-42)-induced brain inflammation and neuronal damage in the rat 103
Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. 103
Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. 101
NGF treatment potentiates c-fos expression in the rat nucleus basalis upon excitotoxic lesion with quisqualic acid 100
Acetylcholine and amino acid neurotransmitters in epidural cups of freely moving rats: effect of acute and chronic treatment with antischizophrenic drugs. 99
Cellular acetylcholine content and neuronal differentiation 98
Recovery of cortical acetylcholine output after ganglioside treatment in rats with lesion of the nucleus basalis. 98
Decrease of acetylcholine release from cortical slices in aged rats: investigations into its reversal by phosphatidylserine. 98
The validity of animal models in the search for drugs for the aging brain. 96
Activation of MAPK pathways in the brain of TgCRND8 mice 96
Effects of novelty and pain on behavior and hippocampal extracellular ACh levels in male and female rats. 93
Activation of the p38MAPK pathway cascade in models of neurodegenerative diseases in the rat in vivo 93
A nutrigenomics approach for the study of anti-aging interventions: olive oil phenols and the modulation of microRNA profiles in mouse brain 93
Inhibition of GSK-3β by lithium improves amyloid pathology and learning and memory functions in a human APP transgenic mouse model 92
Administration of amyloid ß-peptides into the medial septum of rats decreases acetylcholine release from hippocampus "in vivo" 89
Effect of serine phospolipids on memory and brain cholinergic mechanisms in aging rats 87
Oleuropein aglycon relieves memory impairments, induces brain autophagy and reduces Aß load in the TgCRND8 mouse model of Alzheimer’s Disease 87
Totale 13.955
Categoria #
all - tutte 44.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.535


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.708 159 126 133 153 51 205 96 162 126 274 95 128
2021/2022939 22 104 49 40 53 54 35 43 51 42 189 257
2022/20232.447 251 296 125 208 221 480 329 125 267 6 79 60
2023/2024742 47 120 154 42 52 83 29 140 7 23 23 22
2024/20256.179 208 627 397 972 1.863 758 72 357 347 146 224 208
2025/2026299 299 0 0 0 0 0 0 0 0 0 0 0
Totale 17.116